ADARx Pharmaceuticals, Inc. (ADRX)
12.67
-1.49
(-10.52%)
USD |
NASDAQ |
Nov 20, 16:00
12.67
0.00 (0.00%)
After-Hours: 16:15
ADARx Pharmaceuticals EPS Diluted (Quarterly) : -0.2749 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2749 |
| June 30, 2026 | -0.2412 |
| March 31, 2026 | -0.2122 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.1694 |
| March 31, 2025 | -0.1456 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -3.432 |
| IRulya Therapeutics, Inc. | -2.311 |
| PepGen Inc. | -0.28 |
| Q32 Bio, Inc. | -0.2622 |
| Bridgebio Oncology Therapeutics, Inc. | -0.4262 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.12M |
| Revenue (Quarterly) | 2.217M |
| Total Expenses (Quarterly) | 30.33M |
| Enterprise Value | 624.20M |
| Gross Profit Margin (Quarterly) | 66.26% |
| Profit Margin (Quarterly) | -1.27K% |
| Earnings Yield | -7.09% |
| Normalized Earnings Yield | -6.985 |